PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC10847306::ACT004096

MR-22

Evidence text

Paper-level observation

Section 3.9: bacterial content in peritoneal lavage fluid of peritonitis mice treated with MR-22 decreased to 7.23 ± 0.36 Log10CFU/mL.
textConfidence: medium

Assay observation

Activity
Antimicrobial
Subtype
Antibacterial
Measure
other
Comparator
=
Raw observation
7.23 ± 0.36 Log10CFU/mL
Normalized measurement
=7.23 other
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Escherichia coli
Assay method
Not reported by source
Sequence
MAKRRKKAKKKAKKAKKRRRRRNH
Standardization
ready simple

Source publication

The antibacterial activity and mechanism of a novel peptide MR-22 against multidrug-resistant Escherichia coli.

Frontiers in Cellular and Infection Microbiology · 2024

DOI 10.3389/fcimb.2024.1334378 PMC10847306
Parent mention

Related peptide identities

PEPDIA-PLP-001966

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.